Cover Image

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Semaglutide, a newly once-weekly glucagon like peptide-1 (GLP-1) receptor agonist, has showed a favorable effect on glycaemic control and weight reduction in type 2 diabetes mellitus (T2DM). This meta-analysis was conducted to evaluate the clinical efficacy and safety of semaglutide in T...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fang-Hong Shi (Author), Hao Li (Author), Min Cui (Author), Zai-Li Zhang (Author), Zhi-Chun Gu (Author), Xiao-Yan Liu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2018-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China
by: Shanshan Hu, et al.
Published: (2022)

Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis
by: Hiroshi Nomoto, et al.
Published: (2023)

Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: A Bayesian network meta-analysis
by: Yanan Ding, et al.
Published: (2024)

Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
by: Xueqin Gao, et al.
Published: (2022)

Efficacy and Safety of Subcutaneous and Oral Semaglutide Administration in Patients With Type 2 Diabetes: A Meta-Analysis
by: Ping Zhong, et al.
Published: (2021)

Once a week
by: Milne, A. A. (Alan Alexander), 1882-1956

Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration
by: Evgenia Koureta, et al.
Published: (2024)

Efficacy and Safety of Ertugliflozin in Type 2 Diabetes: A Systematic Review and Meta-Analysis
by: Li Liu, et al.
Published: (2022)

Cardiometabolic Modulation by Semaglutide Contributes to Cardioprotection in Rats with Myocardial Infarction
by: Yan H, et al.
Published: (2024)

Efficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis
by: P Ravindra Babu, et al.
Published: (2017)

Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis
by: Geo Neul Park, et al.
Published: (2024)

Semaglutide for the treatment of obesity
by: Rafał Oleszczuk, et al.
Published: (2022)

Appraisal of Non-Cardiovascular Safety for Sodium-Glucose Co-Transporter 2 Inhibitors: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials
by: Fang-Hong Shi, et al.
Published: (2019)

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004)

Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide
by: A. S. Ametov, et al.
Published: (2024)

Semaglutide-associated bullous pemphigoid
by: Clayton P. Burruss, BS, et al.
Published: (2021)

Efficacy and Safety of Mesenchymal Stem Cells in Treatment of Complex Perianal Fistulas: A Meta-Analysis
by: Fang Cheng, et al.
Published: (2020)

Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
by: Inaishi J, et al.
Published: (2022)

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children
by: Torsak Bunupuradah, et al.
Published: (2015)

Semaglutide in the Treatment of Diabetes and Associated Obesity
by: Rafal Makuch, et al.
Published: (2024)

Contractile Effects of Semaglutide in the Human Atrium
by: Joachim Neumann, et al.
Published: (2024)

PP 5.2 - 00072 Simulations for Once Weekly Dosing of Oral Lenacapavir
by: N. Shaik, et al.
Published: (2022)

Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis
by: Rakieh C, et al.
Published: (2014)

Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in China
by: Zhen Feng, et al.
Published: (2023)

Extended Efficacy of Once-Daily Atomoxetine in ADHD
by: J Gordon Millichap
Published: (2004)

Clinical Pharmacokinetics of Semaglutide: A Systematic Review
by: Yang XD, et al.
Published: (2024)

Semaglutide: a game changer for metabolic diseases?
by: Agostino Milluzzo, et al.
Published: (2022)

Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
by: Chen X, et al.
Published: (2022)

Effects of once-weekly shallow water aerobic exercise on functional performance in elderly women
by: Veronika Kramperová, et al.
Published: (2016)

Efficacy and Safety of Non-Vitamin K Anticoagulants for Atrial Fibrillation in Relation to Different Renal Function Levels: A Network Meta-Analysis
by: Hao Jin, et al.
Published: (2020)

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary
by: Susan G Ball, et al.
Published: (2013)

Once-Weekly Somapacitan as an Alternative Management of Growth Hormone Deficiency in Prepubertal Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
by: Ghina Tsurayya, et al.
Published: (2024)

Enhanced Oral Efficacy of Semaglutide via an Ionic Nanocomplex with Organometallic Phyllosilicate in Type 2 Diabetic Rats
by: Gyu Lin Kim, et al.
Published: (2024)

Effects of once-weekly dulaglutide on juvenile type 2 diabetes mellitus and obesity in Korea: a pilot study
by: Ji Young Seo, et al.
Published: (2023)

Clinical Efficacy and Safety of Stem Cell-Based Therapy in Treating Asherman Syndrome: A System Review and Meta-Analysis
by: Yiming Zhao, et al.
Published: (2020)

Dose-dependent erythema nodosum after initiation of semaglutide
by: Jeffrey Sobieraj, MD, et al.
Published: (2024)

Population pharmacokinetic of paracetamol and atorvastatin with co‐administration of semaglutide
by: Emilie K. Langeskov, et al.
Published: (2022)

Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer
by: Xue Zhang, et al.
Published: (2024)

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
by: Xiaoyi Chen, et al.
Published: (2023)

Effects of Once-a-week Interval Training Based on Body Mass Index and Exercise Frequency
by: Yonghwan Kim, et al.
Published: (2018)